2018 press releases
- ESMO 2018 - First evidence of the beneficial effect of a new drug guided by genome anomaly on breast cancer
Press release, 20 october 2018 - Gustave Roussy presentations at ESMO 2018
Press kit, 18 october 2018 - Predicting the response to immunotherapy using artificial intelligence
Press release, 27 August 2018 - Researchers map ‘family trees’ of acute myeloid leukaemia for the first time in patients treated with enasidenib
Press release, 16 July 2018 - Thanks to 1.3 million euros support funding from the Fondation ARC, Gustave Roussy is hiring an expert big data researcher
Press release, 10 July 2018 - ASCO 2018 - Validation of the efficacy of trabectedin in metastatic soft tissue sarcomas
Press release, 4 June 2018 
ASCO 2018 - Gustave Roussy's presentations highlights
Press Kit, 30 May 2018- Death of Professor Thomas Tursz
Press release, 3 May 2018 - PEP-Therapy, Institut Curie and Gustave Roussy obtain 2,9 M€ to develop a novel peptide in oncology
Press release, 17 April 2018 - Gustave Roussy and Protagen AG collaborate to improve the risk profiling of cancer patients undergoing immunotherapy
Press release, 10 April 2018
Catégorie de la page:
